CT-179

N/A

Report date: 2023/06/27 13:36:38
NME

Base Information

Drug NameCT-179
Drug Alias NameCT-179
ClassificationSmall molecules
Mechanisms of ActionOligodendrocyte transcription factor 2 inhibitors
TargetsOligodendrocyte transcription factor 2
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCurtana Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCatalent IncCurtana Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A